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The introduction of biospectroscopic screening allows rapid in-situ diagnosis of 
antibiotic resistance in microbiomes as well as real-time detection of population 
dynamics and determination of genotype flexibility (e.g., HGT process and microbial 
response to antibiotic pressure) via monitoring phenotype differentiation, which can 
significantly improve the understanding of antibiotic resistance in the clinical and 
physical environment. 
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Abstract 
 
There is an increasing need to investigate microbiomes in their entirety in a variety of 
contexts ranging from environmental to human health scenarios. This requirement is 
becoming increasingly important with emergence of antibiotic resistance. In general, more 
conventional approaches are too expensive and/or time-consuming and often predicated on 
prior knowledge of the microorganisms one wishes to study. Herein, we propose the use of 
biospectroscopy tools as relatively high-throughput, non-destructive approaches to profile 
microbiomes under study. Fourier-transform infrared (FTIR) or Raman spectroscopy both 
generate fingerprint spectra of biological material and such spectra can readily be 
subsequently classed according to biochemical changes in the microbiota, such as emergence 
of antibiotic resistance. FTIR spectroscopy techniques generally can only be applied to 
desiccated material whereas Raman approaches can be applied to more hydrated samples. 
The ability to readily fingerprint microbiomes could lend itself to new approaches in 
determining microbial behaviours and emergence of antibiotic resistance. 
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1. Microbiomes and their response to the natural environment 
Microbial communities, including bacteria, archaea, viruses, protists or fungi, play a vital role 
in many ecosystems. Global carbon cycles in the ocean, for instance, at least 50% of carbon 
dioxide is fixed through photosynthesis providing the energy for microbial respiration and 
reproduction
1, 2
. Human health is also highly dependent on microbes since a very abundant 
mix of bacterial species symbiotically survives within humans and many principal organs are 
their habitats. The skin surface is the largest habitat with multiple regional variations in 
cellular architecture and environmental exposures for microbes, where the density of bacteria 
can reach 10
7
 cells per square centimetre
3
. However, bacteria colonizing on external surfaces 
only count for some 10% (i.e., 10
14
 bacterial cells to 10
13
 human cells) while the rest 90% 
comprise the commensal microbiome living in the body
4-9
. A majority of these microbial cells 
exist in the gastrointestinal tract (GIT) and constitute the human intestinal microbiota, which 
has a concentration of 10
12
 CFU/g and probably represents one of the densest, most 
biodiverse and rapidly evolving bacterial ecosystems on earth
4-9
. Another representative 
example is the microbial flora in the oral cavity as the entrance of the digestive tract; over 
500 microorganism species have been identified and can attach to oral surfaces and colonize 
to form a microbial matrix, e.g., dental plaque or oral biofilm
10
. The dynamics of human host 
microbial communities account for many diverse phenomena associated with public health 
issues, e.g., changes in the gut microbial community may be linked to metabolic disorders, 
obesity and Crohn’s disease
11
. 
Antibiotics are widely used to treat microbe-induced diseases and are also applied at 
sub-therapeutic levels via animal feed to maintain meat quality and quantity. Since Sir 
Alexander Fleming identified penicillin in 1928, the environment has become the primary 
receiver for most applied antibiotics and their residues via excretion of human and animals
12-
18
. Currently, antibiotics are ranked as the third most commonly prescribed class of agents, 
and frequently used in human medicine, agriculture, aquaculture and the agri-food industry, 
resulting in an enormous amounts of antimicrobial usage
19
. Accordingly, antibiotic misuse 
may result in a seriously antibiotic-abundant circumstance for microbes as well as humans. 
Consequently, in response to such environmental stimuli, bacteria acquire the capability of 
antibiotic resistance, and ultimately superbugs may emerge
20
. It is worth highlighting that 
microbiota from humans and natural environments are not separated but connected via 
various routes of exposure. For example, horizontal gene transfer (HGT) allows rapid 
development of genetic divergence and therefore leads to virulence, antibiotic resistance, and 
xenobiotic metabolism, spreading through microbe populations inhabiting in human bodies 
and natural environments
21
. HGT accelerates the spread of antibiotic resistance genes (ARGs) 
and emergence of superbugs, which is a lethal threat to humans and therefore a major focus 
of scientific interest
22, 23
. 
With such growing concerns, ARGs and their relevant mechanisms have been identified 
in clinical and environmental contexts
12-18, 24-27
. Many approaches have been applied to 
investigate their existence and spread as well as their dynamics within natural microbiota. 
Herein, we briefly discuss the conventional methods used to determine antibiotic resistance 
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and ARGs within the microbial community, both phenotypically and genetically, as well as 
how biospectroscopy can be applied to fingerprint microbiomes and microbial antibiotic 
resistance. 
 
2. Conventional biological approaches to determine microbial antibiotic resistance 
Research into microbial antibiotic resistance primarily uses different techniques and 
methodologies, generally categorized as function- and molecular-based methods according to 
focus, i.e., function-based approaches aim at particular behaviour or mechanisms of 
individual microbes based on their roles or characteristics, while molecular-based approaches 
target in high-throughput fashion the molecular components within the complex microbiotas. 
2.1 Function-based approaches 
Culturing is the most applied function-based approach to determine microbial response to 
antibiotics
2, 28, 29
 due to its inherent merit which is a focus on individual strains, instead of the 
interrogated complexity and diversity of the whole microbiota
30, 31
. Most known antibiotic-
resistant microbes and genes are identified by direct culturing, isolate purification, and further 
investigation into their resistance profiles
25,32, 33
. For example, colonies grown with 
antibiotics are screened for the presence of antibiotic biomarkers, located on either plasmids 
or chromosomes
33
. However, >90% bacteria are currently unculturable but functional in-
situ
34-36
. Culture-dependent methods are always questioned for their ability to represent the 
real scenario and for an underestimation of ARG abundance
31
. Some improved techniques, 
such as stable isotope probing (SIP) and magnetic nanoparticle-mediated isolation, further 
enumerate the functional fractions, not individual, from the total microbiota
37, 38
. 
2.2 Molecular-based approaches 
Instead of targeting microbes with specific functions, molecular-based approaches deal with 
microbiota as an integrated system by directly extracting biological components. With the 
rapid development of molecular tools, molecular-based approaches have evolved from 
polymerase chain reaction (PCR) and denaturing gradient gel electrophoresis (DGGE) to 
high-throughput sequencing and Omics
31, 39, 40
, uncovering ARGs from all the 
microorganisms within a microbiota, including those uncultured
39, 41-43
. Notably, the recent 
development of Omics, from genomics to proteomics, allows generation of large-scale 
datasets for cellular components (DNA, RNA, and proteins) compositions, interactions and 
profiles, yielding a comprehensive database of genetic functions of ARGs
40
, e.g., isolating 
novel ARGs from microbial communities of human oral and soil
39, 44
. However, molecular-
based approaches have an inherent insufficiency in confirming behavioural functions and 
linking those functions to identities of antibiotic-resistant strains. Meanwhile, as destructive 
methods of collecting cellular components, molecular-based approaches may not meet the 
need for in-situ diagnosis of antibiotic resistance in real-time. 
2.3 Which is more important? 
Individual vs. microbiome. It is hard to answer which, single cells or the whole communities, 
Page 5 of 22 Integrative Biology
In
te
gr
at
iv
e
B
io
lo
gy
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
27
 A
pr
il 
20
17
. D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f C
en
tra
l L
an
ca
sh
ire
 o
n 
27
/0
4/
20
17
 1
4:
52
:2
0.
 
View Article Online
DOI: 10.1039/C7IB00009J
5 
 
needs to be investigated to better understand antibiotic resistance in the microbiome. ARGs 
and antibiotic resistance mechanisms vary between individuals, implying insight into the 
single cell may provide more comprehensive information. On the other hand, although 
individual cells hold their respective ecological niche, they also contribute to the overall 
function of the microbiome as a whole. Since most microbes are somewhat dormant in the 
natural environment within developing communities such as mat, sludge or biofilm, it is 
worth paying more attention for clinical purposes to the response of the microbiome to 
antibiotics, rather than that of individual cells, i.e., typically, an unnecessary single-cell-level 
test is required for the diagnosis of diseases. Biofilm, for instance, consists 2% to 15% of 
microorganisms with the remainder being their self-produced matrix of extracellular 
polymeric substances (~90%) secreted by microbes making individual cells stick together and 
colonize on a surface; this overall community performs functional tasks similar to multi-
cellular organisms for adaptation to environmental changes
45-49
. Extracellular polymeric 
substances matrix facilitates communication between cells (e.g., such as quorum sensing), 
maintains biofilm hydration and protects microorganisms against environmental stresses. The 
chemical composition and structure of extracellular polymeric substances depend on cell 
species, metabolic activity, nutrient availability, biofilm maturity level and physicochemical 
conditions. Biofilm formation offers microbes an entirely different lifestyle weighing against 
the planktonic state providing protection from external exposures (e.g., antibiotics) for the 
community
45-49
. Recently, the field of single cell study has developed some breakthroughs 
allowing characterisation and interrogation of particular microbes at reasonable levels
50-60
. 
However, these remain insufficient to fulfil the need to study microbial interactions within the 
microbiome and their surrounding environment. Thus, further research into the functionality 
of the entire microbiome is needed. 
Phenotype vs. genotype. Stochasticity in gene expression may induce genetically-identical 
cells under the same environmental exposures to express significant variation in molecular 
content and discriminating differences in phenotypic characteristics; this implies cell 
functions may be altered by non-genetic regulation providing a mechanism for phenotypic 
and cell-type diversification regardless of genotype
61-63
. Such phenotypic heterogeneity helps 
microbes survive exposures to antibiotics owing to the fact that a small genetically-identical 
subset of persistent cells can survive an extended period and get over the exposure time
61
. 
This phenomenon may bring another challenge regarding in-situ diagnosis of antibiotic 
resistances of interrogated microbiomes since the phenotype of the microbiome may be 
unpredictable even under an acknowledged circumstance due to the influence of epigenetic 
factors
64, 65
. Therefore, finding a new approach that can quickly screen the phenotype of a 
microbiome to determine the in-situ bacterial antibiotic resistance in real-time is urgently 
required. 
3. A new dawn for biospectroscopy in microbiological research 
3.1 Principles of biospectroscopy 
Biospectroscopy encompasses a range of techniques that allow the spectroscopic examination 
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of biological samples. Such spectroscopic measurements are usually based on electronic 
transitions and vibrational changes of chemical bonds with spatial resolutions from the 
microscopic to the macroscopic. These both examine the morphological contrast in biological 
samples and uncovers elemental or molecular information via further determination
66
. 
Infrared (IR) or Raman spectroscopy are the two most applied biospectroscopy techniques 
since the 1960s
67, 68
. 
 
Figure 1. The principle of the biospectroscopic fingerprinting in identifying microbial 
species, examining food security and diagnosing pathogen-induced diseases. IR spectroscopy 
is capable of measuring the electric dipole state of chemical bonds in cellular molecules; 
Raman spectroscopy is a complementary tool exploiting the inelastic scattering of the 
targeted biological samples even under a hydrated environment. 
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When biomolecules contain chemical bonds with an electric dipole moment, these 
vibrations are detectable and measurable by IR spectroscopy
69
. Categorized according to 
wavelengths (i.e., near-IR, mid-IR or far-IR), mid-IR (MIR) spectroscopy (4000-400 cm
-1
 in 
wavenumbers) is the most applied in biospectroscopy because it not only includes overtones 
but also contains fundamental vibrational transitions, providing inherently stronger signal 
intensities in terms of the increased absorption cross-section
70
. In 1991, FTIR spectroscopy 
was innovatively introduced as a sensitive and rapid screening tool for characterization, 
classification and identification of microorganisms
71
. Since then, FTIR spectroscopy has been 
extensively used in microbial research
72-75
. Among FTIR spectroscopic techniques, the most 
frequently applied IR spectroscopic techniques are transmission, transflection or attenuated 
total reflection (ATR)
72
. ATR-FTIR spectroscopy (Figure 1), for instance, which employs an 
internal reflection element with a high refractive index (e.g., diamond, germanium or zinc 
selenide), directs the IR beam for the total internal reflection and produces an evanescent 
wave that penetrates beyond the element by 1 µm to 2 µm. It is used to interrogate biological 
samples allowing absorption of IR light and subsequently production of absorbance spectra
69, 
72
. This process can reveal biochemical information regarding cellular changes or alterations 
of samples. However, there is a significant limitation within FTIR in that water from 
instrumentation or samples may induce reduction of IR light transmission
69, 72
. Hence, it is 
crucial to purge the instrumentation with dry air or nitrogen, as well as desiccants to remove 
any water vapour before spectral acquisition
72
. FTIR is a valuable metabolic fingerprinting 
tool owing to its abilities to characterize cellular composition
72-78
. In the mid-IR 
spectroscopy, the biochemical fingerprint region is from 1800 - 900 cm
-1
, and representative 
peaks include: lipids (~1750 cm
-1
), Amide I (~1650 cm
-1
), Amide II (~1550 cm
-1
), Amide III 
(~1260 cm
-1
), carbohydrates (~1155 cm
-1
), asymmetric phosphate stretching vibrations (νas 
PO2
-
, ~1225 cm
-1
), symmetric phosphate stretching vibrations (νsPO2
-
, ~1080 cm
-1
), glycogen 
(~1030 cm
-1
), protein phosphorylation (~970 cm
-1
)
69, 72, 77, 79, 80
. These peaks can be derived as 
biomarkers for characterization of microbial cell types (even at subspecies level) and 
diagnosis of microbe-induced diseases
72-78
. Metabolomics is a critical field that 
biospectroscopy could complement in order to investigate microbial metabolism. 
Raman spectroscopy, a complementary biospectroscopic technique to FTIR, can generate 
information regarding chemical bonds even under a hydrated environment
81-85
. The 
monochromatic light in the near-IR, visible or UV range is used in Raman spectroscopy 
(Figure 1) to exploit the inelastic scattering or Raman effect. In this process, the excitation of 
photons to virtual energy states and the resultant loss (Stokes) or gain (anti-Stokes) of energy 
occurs because of the interaction of light with vibrational modes associated with chemical 
bonds within the sample
80, 86
. This shift in energy is indicative of discrete vibrational modes 
of polarizable molecules, and thus a qualitative measurement of the biochemical composition 
can be obtained
80, 86
. However, the inelastic scattering does not occur efficiently, the 
incidence is <1% of the total photons absorbed by the molecules. Thus, backward light is 
then applied filtering off other interference, but the Raman scattering can reach the detector. 
Typically, the informative region of wavenumbers for biological samples is located within 
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400-2000 cm
-1
 and 2700-3500 cm
-1
, including proteins (1500-1700 cm
-1
), carbohydrates 
(470-1200 cm
-1
), phosphate groups of DNA (980, 1080 and 1240 cm
-1
) and higher-frequency 
bond vibrations of CH, NH and OH stretching in lipids and proteins
80, 87
. Applications of 
Raman spectroscopy in microbiology include bacterial discrimination, isolation, and 
identification
88-90
. 
3.2 Applications of biospectroscopy in microbial research 
Compared to the conventional tools employed for identifying and characterizing the 
microbiome, biospectroscopy requires minimal sample amount and preparation, and is non-
destructive and relatively high throughput
69, 72, 80
. Specifically, the minimal sample volume 
for ATR-FTIR and Raman spectroscopy is 3 µL and 1 µL respectively, much lower than those 
required in PCR, high-throughput sequencing, and Omics which require high quality and 
amounts of DNA template extracted from several millilitres or grams of environmental 
samples. Additionally, biospectroscopy does not require extra labelling, primer design, and 
enzymatic reaction, significantly reducing the cost and time in diagnosing. More importantly, 
the non-destructive features of biospectroscopy allow its application in vivo and in situ. Some 
successful microbial applications of biospectroscopy (Figure 1) include characterization of 
hospital isolates and rapid quantitative detection of the microbial spoilage of food products
71, 
77, 79, 91, 92
. There is no doubt that biospectroscopy is a robust tool for distinguishing bacterial 
responses to environmental exposures due to its particular attributes of being non-destructive, 
non-intrusive, high throughput and label-free
69, 72
. When coupled with conventional 
microscopy, biospectroscopy can be used to reproduce cell architecture from both the visual 
and biochemical perspective by the passing of spectral data through a variety of 
computational algorithms and capture of pictures simultaneously
69, 72
. It allows visualized 
monitoring and spectral interrogation undertaken in-situ in real-time, which is very helpful 
towards understanding the actual interactions between microbes and physical environment
66, 
69, 72, 77, 80, 93, 94
. In the history of microbiological research, the microbiome is a particular 
hotspot in microbial ecology, challenging to all approaches to investigate it but bringing 
possibilities for biospectroscopy to be applied. As a very complicated bio-matrix, 
microbiomes contain various compositions contributing to the overall spectra, including 
extracellular polymeric substances (EPS), cell membrane, and the cytoplasm. The 
characteristic spectral peaks, e.g., biological macromolecules, may assess the existence and 
composition of biofilms by summarising the wavenumbers of detected peaks. Most EPS 
induced biomarkers, for instance, fall in the range of 1700 - 100 cm
-1
 in Raman 
spectroscopy
95
. Also, the comparison between the microbial biofilms and planktonic 
communities could reveal relevant biochemical information
96
. Specifically, Bosch et al. found 
FTIR spectra of biofilms demonstrated higher intensity in the absorption bands associated 
with polysaccharides (1200 - 900 cm
−1
 region) and vibrational modes of carboxylate groups 
(1627, 1405, and 1373 cm
−1
) than those of the planktonic
74
, showing evidence of dramatic 
difference of microbial living style within such communities. 
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4. Fingerprint microbiome via biospectroscopy 
4.1 State of art 
Owing to the non-destructive and high-throughput possibilities, biospectroscopy has many 
advantages in diagnosing antibiotic resistance within a microbiome over other approaches, 
either function- or molecular-based ones. It allows fast and low-cost screening for an 
enormous number of samples and also provides a chance for further analysis of relevant 
mechanisms. Additionally, biospectroscopy is capable of monitoring real-time population 
dynamics and subsequently providing information of genotypic changes. However, until now, 
few biospectroscopy-based studies have focused on microbial antibiotic resistance, and all of 
the published studies
97-99
 investigate pure cultures. Lack of insight into microbiome structures 
in situ highlights the urgent need for novel approaches. The primary challenges currently 
include the lack of a reliable database, routine protocols, and reproducible computational 
analysis, which determine the feasibility of biospectroscopy distinguishing biomarkers 
representing antibiotic resistance from the numerous fingerprints in environmental 
backgrounds. 
Herein, we propose a state-of-the-art biospectroscopic application in assessing 
microbial antibiotic resistance within a microbiome. Within a microbiota of interest, there is 
no doubt biospectroscopy has the ability to allow the quick identification of microbial species 
within a well-built dataset
97
. Furthermore, biospectroscopy can diagnose microbe-induced 
diseases in clinical settings contributing to the advantages of early detection and stratification 
of at-risk patients to initiate timely and appropriate treatment
100-103
. Raman spectroscopy has 
successfully identified sepsis in blood plasma from 70 patients with a satisfactory sensitivity 
of 1.0 and specificity of 0.82
101
. The feasibility of biospectroscopic investigation into 
microbial alterations induced by exposures has also been evaluated. Riding et al. applied IR 
spectroscopy to fingerprint microbes following exposure to carbon nanoparticles, and 
revealed concentration- and size-dependent changes in cellular components
104
. Another 
study
105
 confirmed the ability of IR spectroscopy to characterize changes induced by carbon 
nanoparticles via investigating their effects in both Gram positive and negative bacteria. 
Some discriminant biochemical markers, i.e., Amide II and carbohydrate, were picked out to 
verify the distinct alterations in bacteria with respective cell wall structures. These studies 
prove that biospectroscopy is not only able to distinguish microbial response to different 
kinds of exposures, but also specify variances resulting from bacterial structures, 
demonstrating its potential to diagnose antibiotic resistance with reliable biomarkers. 
To investigate in-situ the construction and composition of microbiota in real-time, a 
non-destructive and non-intrusive method is required to delineate differentiation. 
Biospectroscopy is such an optical sensor, an in-situ non-labelling complementary to other 
molecular-based techniques, by directly and remotely measuring molecular vibration spectra 
in living cells
106
 and biofilms
107
. Given this, we propose a new system for characterizing 
antibiotic resistance within whole microbiomes via a rapid and high-throughput manner 
(Figure 2). Firstly, by well-trained databases, the abundance of ARGs or microbes with 
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ARGs in microbiotas can be quantified by evaluating the alteration ratio of biomarkers from 
multivariate statistical analysis. Furthermore, the dynamics of ARGs in microbiotas might be 
assessed in real-time via the interrogation of changes in biomarker change. Achieved in-situ 
and real-time investigation of antibiotic resistance, the ultimate goal of this approach is to 
monitor and diagnose both the presence and change of ARGs in unknown environmental or 
human samples of interest, differentiating alterations of discriminating biomarkers in-situ and 
real-time without referencing trained datasets. 
 
Figure 2. Schematic diagram of biospectroscopy fingerprinting microbiome for antibiotic 
resistance. Portal bio-spectroscopic devices achieve in situ and real-time interrogation of 
spectra from the samples of interest, e.g., human microbiome and livestock farm microbiome. 
The fingerprints are further processed via computational analysis (pre-processing, feature 
extraction, classification, discrimination, and differentiation) to distinguish the spectral 
biomarkers of antibiotic resistance. Comparing to well-trained databases with both positive 
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and negative controls, the biomarker alterations can examine the antibiotic resistance 
capability of the targeted microbiome or even quantify the abundance of antibiotic resistance 
genes. 
 
4.1 Proof of concept 
Our pre-validating results indicate biospectroscopy can determine the abundance of bacteria 
with ARG in microbiome (Figure 3A), despite disparate bacterial types and community 
composition (Gram-positive or Gram-negative; Figure 3B). From the well-trained dataset and 
discriminating biomarkers (Figure 3C), the fingerprints of unknown microbiomes are 
allocated and assigned with their ARGs abundance after encoding. Furthermore, both the 
static and dynamic microbial matrices can be quantified by biospectroscopy due to inherently 
non-destructive and non-intrusive attribute (Figure 3D). Here, biospectroscopy is validated as 
a high throughput screening method for characterization of microbial composition and ARGs 
abundance in complex matrices. 
 
Figure 3. Pre-validation proves the feasibility of interrogating the abundance of ARGs and 
ratio of Gram-positive to Gram-negative bacteria in microbiomes. ARGs identification in 
microbiome by biospectroscopic fingerprints via a Bruker TENSOR 27 FTIR spectrometer 
(Bruker Optics Ltd., UK) equipped with a Helios ATR attachment containing a diamond 
internal reflection element (IRE). Instrument parameters were set at 32 scans, 16 cm
-1
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resolution. A total of 30 spectra were acquired for each treatment (3 replicates) through the 
ATR magnification-limited viewfinder camera. (A) Prediction of ARGs abundance in 
artificial microbial communities containing different compositions of two Acinetobacter 
baylyi mutants, ADP_kan
-
 and ADP_kan
+
, which are genetically identical apart from the 
kanamycin resistance gene located on the chromosome of ADP_kan
+
. Under kanamycin 
antibiotic pressure, i.e., treated with final concentration of kanamycin, the discriminant 
biomarkers were (~980 cm
-1
), Oligosaccharide C-OH stretching band (~1138 cm
-1
), 
Deoxyribose (~1188 cm
-1
), Amide III (~1242 cm
-1
), In-plane CH bending vibration from the 
phenyl rings (~1500 cm
-1
), C=O stretching, lipids (~1740 cm
-1
). The LDA distance is 
positively correlated with the ratio of ADP_kan
-
/ADP_kan
+
 and the linear regression, 
therefore, can be used for ARG abundance calculation. (B) Prediction of microbial 
community composition artificial microbial communities containing Gram-positive 
(Mycobacterium vanbaalenii, Gram
+ve
) and Gram-negative (Acinetobacter baylyi ADP_kan
+
, 
Gram
-ve
) bacteria. The positive correlation between LDA distance and the ratio of Gram
+ve
/ 
Gram
-ve
 helps in determining the abundance of each strain. (C) Dataset from LDA 
differentiation of four reference bacterial strains (AGR
+
: bacteria I and bacteria II with ARG; 
AGR
-
:  bacteria III and bacteria IV with no ARG). The dataset is well trained for separating 
ARG
+
 and ARG
-
 bacteria. (D) LDA differentiation of unknown microbiome (U1, U2, and U3) 
compared to training dataset to determine the abundance of ARG. Based on the values 
generated from LDA analysis, their biochemical distances can be calculated. These results 
validate bio-spectroscopy is capable of characterizing and quantifying ARGs of microbes via 
their phenotypes in both genetically identical and differential microbial communities. Also, it 
can be used to determine antibiotic resistance of unknown samples by calculating their 
biochemical distances. 
 
5. Challenges and solutions 
5.1 Dataset 
As mentioned above, a well-trained dataset is the key for biospectroscopic fingerprinting 
microbiome and also the first fundamental problem challenge concerned which can eliminate 
confounding factors, i.e., criteria may contribute a disruption to the core purpose of the study. 
To achieve this goal, the database of relevant molecular fingerprint and their assignments 
(such as nucleic acids, proteins, polysaccharides, carbohydrate, and lipids) have to be well-
characterised since the bio-spectroscopic classifications are based on calculating alterations 
of interaction involved cellular compositions. This work may significantly improve bio-
spectroscopy from both quantity and quality criteria
108
. Detailed information of the most 
widely used peak frequencies and their assignments refers to the reviews of IR 
spectroscopy
108
, Raman spectroscopy
52, 87
, and ratios (X cm
-1
/Y cm
-1
)
109
. These peaks with 
remarkable alterations are determined as discriminating biomarkers for diagnosis of changes 
resulted by specific exposures in many studies
69, 87, 104, 105, 108, 110
. However, no 
biospectroscopy-relevant study has yet been found associated with biomarkers for antibiotic 
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resistance of microbiomes. 
5.2 Growth phase and environmental variants 
Another major concern for the overall study (i.e., confounding factors) is bacterial 
communities are incredibly complicated in terms of their composition, species, dynamics of 
population, growth phase and nutrient depletion impacts
111-114
. Growth phase effect for 
instance, which may result in remarkable discrepancies within cell growth circle regarding 
physical features and biochemical compositions. Ede et al.
115
 reported all the examined 
species showed significant spectral differences through their growth phases in a study of 
assessing cell population growth via ATR-FTIR spectroscopy. They found B. 
stearothermophilus had a major change associated with lipid content and reached peak 
position during the log phase; for the halophiles H. salinarium and H.morrhuae, the most 
significant alteration was the concentration of sulphate ion. Mainly, at the mid-log phase, A. 
aceti cells showed increasing polysaccharide content along with and also a maximum change 
of lipid content was noticed during the log phase. These growth phase induced changes may 
lead to distinct responses of microbes to exposures
115-118
. 
  
Figure 4. Pre-validation of solutions for proposed challenges of growth phase and nutrients. 
The well-trained dataset eliminating other environmental interference is built-up in several 
steps: 1) Reference dataset acquisition from individual single cell of different species 
representing their biospectral attributes; 2) Biospectra acquisition from the targeted 
microbiome; 3) Biospectra acquisition from the targeted microbiome postexposure to 
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antibiotics to recognize and separate the discriminating spectral alterations via multivariate 
analysis; and, 4) The identical and consistent spectral alterations representing antibiotic 
resistance markers are clustered for interrogating the targeted microbiome. 
 
A substantial alteration gradient of bio-spectra is noticed along with growth phase and 
nutrient conditions, respectively. However, discrimination of antibiotic resistance biomarkers 
is independent of growth phase and nutrient conditions (Figure 4). The biomarkers of 
antibiotic resistance, i.e., phenylalanine (protein assignment) (~1004 cm
-1
 and ~1376 cm
-1
), 
hydroxyapatite, carotenoid, cholesterol (~957 cm
-1
), uracil-based ring breathing mode (~780 
cm
-1
), carbohydrates (~1105 cm
-1
), phenylalanine, hydroxyproline (~1586 cm
-1
), are 
significantly discriminated from those of growth phases, phenylalanine or bound & free 
NADH (~1000 cm
-1
), phosphatidylinositol (~776 cm
-1
), C-C-N
+
 symmetric stretching (lipids) 
or C-O-C ring (carbohydrate) (~877 cm
-1
 and ~1495 cm
-1
), Amide I (~1634 cm
-1
 and ~1530 
cm
-1
); and nutrients, uracil-based ring breathing mode (~780 cm
-1
), C-C-N
+
 symmetric 
stretching (lipids) or C-O-C ring (carbohydrate) (~877 cm
-1
), phenylalanine or bound & free 
NADH (~1000 cm
-1
), proline, hydroxyproline or glycogen and lactic acid (~918 cm
-1
, ~1695 
cm
-1
 and ~1375 cm
-1
) implying biospectroscopic is able to identify antibiotic resistance 
within a microbiome regardless of impacts from growth phase and nutrient condition. 
Therefore, these discriminating biomarkers associated with antibiotic resistance reveal the 
potential feasibility for in-situ diagnosis of real samples despite environmental variants. It is 
worth mentioning that discrimination of antibiotic resistance biomarkers might be also 
affected by the complicated effects of antibiotics on both targeted microbiome and their 
matrix environment, particularly in case of interrogating biofilm on mammalian tissues. The 
production of tissue mucus and other components or the interference signals from 
mammalian tissues themselves can bring challenges in distinguishing the proper biospectral 
biomarkers. Although no previous report has answered this question yet, some potential 
solutions eliminating background noise include separating microbiome from via optical 
tweezers
119
 or flow cytometry 
120
. 
5.3 Computational analysis 
It needs to be highlighted the most vital component associated with biospectroscopic 
determination for antibiotic resistance of microbiome is to find discriminating biomarkers, 
i.e., the most absolute and representative peaks derived from acquired spectra, allowing 
subsequently high throughput screening for determination of antibiotic resistance. Although 
some alterations of biomarkers can be visualized by eyes, the questions always emerge 
regarding the existence of noticed difference and the reliability of subjective assessing by 
eye. Hence, computational analysis is applied to exam the data due to the acquired spectrums 
holding an enormous number of features. 
The pre-processing is the first step of computational analysis which aims to reduce 
effects resulted from spectral acquisition and subsequently enhance the robustness and 
accuracy as well as making all the raw data comparable
72
. Categories of pre-processing 
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include de-noising, spectral correction, normalization and combinations of these processes. 
For a raw dataset of Raman, a noise-reduction smoothing step is commonly applied to 
increase the SNR (signal-to-noise ratio) and highlight spectral features associated with 
biochemical information
69
. PCA is also used to achieve the purpose of de-nosing because the 
most valuable features of spectra can be represented by several significant PCs while the rest 
PCs containing a majority of noise can be ignored. Furthermore, there is a huge challenge in 
the procession of raw data, i.e., sloped or oscillatory baselines associated with resonant Mie 
scattering in IR spectroscopy or fluorescence in Raman spectroscopy
72
. To solve this issue, 
rubber band baseline correction is applied for IR which produced a convex polygonal line to 
correct the bottom edges of the spectra; and polynomial fit for Raman, which generates a 
polynomial baseline to adjust the spectral minima
121
. Also, the most vital part of pre-
processing is the normalization, which eliminates the confounding factors, thickness or 
concentration, for instance, making acquired spectra comparable within intra-class and inter-
class. For biological samples, Amide I (~1650 cm-1)/II (~1550 cm
-1
) is usually applied after 
baseline correction for IR data; and vector normalization (Euclidean or L2-norm) is used for 
Raman data
72, 121
. 
Moreover, the multivariate statistical analysis is an ideal tool for spectral analysis. In 
2010, Martin et al. proposed two objectives for spectral assessing biological materials using 
multivariate statistical analysis: (i) to determine similarities and differences between classes 
(categories within the dataset, e.g., cell types); and (ii) to identify the spectral bands that 
mostly relate to these similarities and differences. So as to meet the objectives, classification 
is introduced as one of the core components in multivariate analysis, which typically relies on 
clustering techniques, such as hierarchical cluster analysis, k-means clustering, fuzzy C-
means clustering and PCA. Furthermore, PCA-LDA is an ideal classification tool to 
investigate intra-class or interclass variation. As compared to PCA alone, the additional linear 
discriminant analysis derives vectors from the principal components (PCs) and minimizes the 
within-category differences (mostly be associated with typical heterogeneity in any biological 
sample) while maximizing between-category discriminating characteristics (i.e., those most 
likely to be induced by treatments or other exogenous contributions)
69, 72, 80
. 
6. Future prospects 
The introduction of biospectroscopic screening allows rapid in-situ diagnosis of antibiotic 
resistance in microbiomes as well as real-time detection of population dynamics and 
determination of genotype flexibility (e.g., HGT process and microbial response to antibiotic 
pressure) via monitoring phenotype differentiation, which can significantly improve the 
understanding of antibiotic resistance in the clinical and physical environment. Furthermore, 
a combination of cultivation-based approaches coupled with fast screening may solve the 
inherent limitation of cultivation that microbial functioning in natural environments is 
difficult to study by cultivation solely due to uncultivable microbes and their complicated 
community constructions
93, 122
. Also, with the non-destructive character of bio-spectroscopic 
fast screening reducing the amount of interrogating targets, many other techniques can be 
attached for further investigation, e.g., single cell sorting
54, 57
, -omics
40
, etc. One good 
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example can be found in Huang’s work describing novel marine strain identification via 
Raman spectroscopy coupled with single-cell genomics
123
. Raman spectra are also reported in 
morphology-specific genomic analysis of human tissues combined with microdissection 
sequencing
124
 or characterizing metabolic alterations in mouse liver coupled with 
metabolomics and transcriptomics
125
. These combinations may significantly enhance the 
study of the relevant mechanisms providing an opportunity for direct determination of 
precisely functional genes and proteins. Ultimately, genotype and phenotype can be linked 
together from the population, single cell, and molecular perspectives to determine the 
antibiotic resistance in the microbiota of interest and consequently help us better understand 
the actual interactions among humans, microbes, and the physical environment. 
  
Page 17 of 22 Integrative Biology
In
te
gr
at
iv
e
B
io
lo
gy
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
27
 A
pr
il 
20
17
. D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f C
en
tra
l L
an
ca
sh
ire
 o
n 
27
/0
4/
20
17
 1
4:
52
:2
0.
 
View Article Online
DOI: 10.1039/C7IB00009J
17 
 
References 
1. M. Breitbart and F. Rohwer, Trends Microbiol., 2005, 13, 278-284. 
2. J. A. Fuhrman, Nature, 2009, 459, 193-199. 
3. N. Fierer, M. Hamady, C. L. Lauber and R. Knight, Proc. Natl. Acad. Sci. U. S. A., 
2008, 105, 17994-17999. 
4. M. Candela, E. Biagi, S. Maccaferri, S. Turroni and P. Brigidi, Trends Microbiol., 
2012, 20, 385-391. 
5. D. A. Hill, C. Hoffmann, M. C. Abt, Y. Du, D. Kobuley, T. J. Kirn, F. D. Bushman and 
D. Artis, Mucosal Immunol., 2010, 3, 148-158. 
6. M. T. Bailey, S. E. Dowd, J. D. Galley, A. R. Hufnagle, R. G. Allen and M. Lyte, 
Brain. Behav. Immun., 2011, 25, 397-407. 
7. C. Jernberg, S. Lofmark, C. Edlund and J. K. Jansson, Microbiology, 2010, 156, 3216-
3223. 
8. K. Lu, R. P. Abo, K. A. Schlieper, M. E. Graffam, S. Levine, J. S. Wishnok, J. A. 
Swenberg, S. R. Tannenbaum and J. G. Fox, Environ. Health Perspect., 2014, 122, 
284-291. 
9. E. A. Mutlu, P. M. Gillevet, H. Rangwala, M. Sikaroodi, A. Naqvi, P. A. Engen, M. 
Kwasny, C. K. Lau and A. Keshavarzian, Am J Physiol Gastrointest Liver Physiol, 
2012, 302, G966-978. 
10. N. Takahashi, 2005. 
11. A. Gonzalez, J. C. Clemente, A. Shade, J. L. Metcalf, S. Song, B. Prithiviraj, B. E. 
Palmer and R. Knight, EMBO Rep, 2011, 12, 775-784. 
12. A. Koluman and A. Dikici,  Crit. Rev. Microbiol., 2013, 39, 57-69. 
13. J. W. Harrison and T. A. Svec, Quintessence int., 1998, 29, 223-229. 
14. X. Ji, Q. Shen, F. Liu, J. Ma, G. Xu, Y. Wang and M. Wu, J. Hazard. Mater., 2012, 
235, 178-185. 
15. J. C. Chee-Sanford, R. I. Aminov, I. J. Krapac, N. Garrigues-Jeanjean and R. I. 
Mackie, Appl. Environ. Microbiol., 2001, 67, 1494-1502. 
16. L. Cantas, S. Q. Shah, L. M. Cavaco, C. M. Manaia, F. Walsh, M. Popowska, H. 
Garelick, H. Burgmann and H. Sorum, Front. Microbiol., 2013, 4, 96. 
17. M. Tandukar, S. Oh, U. Tezel, K. T. Konstantinidis and S. G. Pavlostathis, Environ. 
Sci. Technol., 2013, 47, 9730-9738. 
18. J. L. Martinez and F. Baquero, Ups. J. Med. Sci., 2014, 119, 68-77. 
19. J. Conly, CMAJ, 2002, 167, 885-891. 
20. M. Sundqvist, Ups. J. Med. Sci., 2014, 119, 142-148. 
21. C. S. Smillie, M. B. Smith, J. Friedman, O. X. Cordero, L. A. David and E. J. Alm, 
Nature, 2011, 480, 241-244. 
22. G. D. Wright, Chem. Biol., 2000, 7, R127-R132. 
23. T. Häusler, Viruses vs. superbugs: a solution to the antibiotics crisis?, Palgrave 
Macmillan, 2006. 
24. P. Southern and P. Berg, J. Mol. Appl. Genet., 1981, 1, 327-341. 
25. K. J. Forsberg, A. Reyes, B. Wang, E. M. Selleck, M. O. Sommer and G. Dantas, 
Science, 2012, 337, 1107-1111. 
26. J. L. Martínez, Science, 2008, 321, 365-367. 
27. A. A. Salyers, A. Gupta and Y. Wang, Trends Microbiol., 2004, 12, 412-416. 
28. T. Schwartz, W. Kohnen, B. Jansen and U. Obst, FEMS Microbiol. Ecol., 2003, 43, 
325-335. 
29. C. Martin, J. Timm, J. Rauzier, R. Gomez-Lus, J. Davies and B. Gicquel, Nature, 
1990, 345, 739-743. 
Page 18 of 22Integrative Biology
In
te
gr
at
iv
e
B
io
lo
gy
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
27
 A
pr
il 
20
17
. D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f C
en
tra
l L
an
ca
sh
ire
 o
n 
27
/0
4/
20
17
 1
4:
52
:2
0.
 
View Article Online
DOI: 10.1039/C7IB00009J
18 
 
30. L. Rizzo, C. Manaia, C. Merlin, T. Schwartz, C. Dagot, M. Ploy, I. Michael and D. 
Fatta-Kassinos, Sci. Total Environ., 2013, 447, 345-360. 
31. D. Nichols, FEMS Microbiol. Ecol., 2007, 60, 351-357. 
32. M. R. Rondon, P. R. August, A. D. Bettermann, S. F. Brady, T. H. Grossman, M. R. 
Liles, K. A. Loiacono, B. A. Lynch, I. A. MacNeil and C. Minor, Appl. Environ. 
Microbiol., 2000, 66, 2541-2547. 
33. N. A. Séveno, D. Kallifidas, K. Smalla, J. D. van Elsas, J.-M. Collard, A. D. 
Karagouni and E. M. Wellington, Rev. Med. Microbiol., 2002, 13, 15-27. 
34. K. Bartscht, H. Cypionka and J. Overmann, FEMS Microbiol. Ecol., 1999, 28, 249-
259. 
35. J. Clardy and C. Walsh, Nature, 2004, 432, 829-837. 
36. W. R. Streit and R. A. Schmitz, Curr. Opin. Microbiol., 2004, 7, 492-498. 
37. S. Radajewski, P. Ineson, N. R. Parekh and J. C. Murrell, Nature, 2000, 403, 646-649. 
38. D. Zhang, J. P. Berry, D. Zhu, Y. Wang, Y. Chen, B. Jiang, S. Huang, H. Langford, G. 
Li and P. A. Davison, The ISME journal, 2015, 9, 603-614. 
39. C. S. Riesenfeld, R. M. Goodman and J. Handelsman, Environ. Microbiol., 2004, 6, 
981-989. 
40. M. Tyers and M. Mann, Nature, 2003, 422, 193-197. 
41. M. O. A. Sommer, G. Dantas and G. M. Church, Science, 2009, 325, 1128-1131. 
42. K. J. Forsberg, 2015. 
43. J. Handelsman, Microbiol. Mol. Biol. Rev., 2004, 68, 669-685. 
44. M. Diaz-Torres, R. McNab, D. Spratt, A. Villedieu, N. Hunt, M. Wilson and P. 
Mullany, Antimicrob. Agents Chemother., 2003, 47, 1430-1432. 
45. H. C. Flemming and J. Wingender, Nat. Rev. Microbiol., 2010, 8, 623-633. 
46. E. Karunakaran, J. Mukherjee, B. Ramalingam and C. Biggs, Appl Microbiol 
Biotechnol, 2011, 90, 1869-1881. 
47. X. N. Lu, D. R. Samuelson, B. A. Rasco and M. E. Konkel, J. Antimicrob. 
Chemother., 2012, 67, 1915-1926. 
48. H. Y. N. Holman, R. Miles, Z. Hao, E. Wozei, L. M. Anderson and H. Yang, Anal. 
Chem., 2009, 81, 8564-8570. 
49. P. S. Stewart, Int. J. Med. Microbiol., 2002, 292, 107-113. 
50. D. Berry, E. Mader, T. K. Lee, D. Woebken, Y. Wang, D. Zhu, M. Palatinszky, A. 
Schintlmeister, M. C. Schmid and B. T. Hanson, Proc. Natl. Acad. Sci. U.S.A., 2015, 
112, E194-E203. 
51. W. E. Huang, M. J. Bailey, I. P. Thompson, A. S. Whiteley and A. J. Spiers, Microb. 
Ecol., 2007, 53, 414-425. 
52. W. E. Huang, M. Q. Li, R. M. Jarvis, R. Goodacre and S. A. Banwart, Adv. Appl. 
Microbiol., Vol 70, 2010, 70, 153-186. 
53. W. E. Huang, Y. Song and J. Xu, Microb. Biotechnol., 2015, 8, 15-16. 
54. W. E. Huang, A. D. Ward and A. S. Whiteley, Environ. Microbiol. Rep., 2009, 1, 44-
49. 
55. M. Li, D. G. Boardman, A. Ward and W. E. Huang, Methods Mol. Biol., 2014, 1096, 
147-153. 
56. M. Q. Li, J. Xu, M. Romero-Gonzalez, S. A. Banwart and W. E. Huang, Curr. Opin. 
Biotechnol., 2012, 23, 56-63. 
57. Y. Song, H. Yin and W. E. Huang, Curr. Opin. Chem. Biol., 2016, 33, 1-8. 
58. Y. Wang, Y. Chen, Q. Zhou, S. Huang, K. Ning, J. Xu, R. M. Kalin, S. Rolfe and W. 
E. Huang, PLoS One, 2012, 7, e47530. 
59. Y. Wang, W. E. Huang, L. Cui and M. Wagner, Curr. Opin. Biotechnol., 2016, 41, 34-
42. 
Page 19 of 22 Integrative Biology
In
te
gr
at
iv
e
B
io
lo
gy
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
27
 A
pr
il 
20
17
. D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f C
en
tra
l L
an
ca
sh
ire
 o
n 
27
/0
4/
20
17
 1
4:
52
:2
0.
 
View Article Online
DOI: 10.1039/C7IB00009J
19 
 
60. P. Zhang, L. Ren, X. Zhang, Y. Shan, Y. Wang, Y. Ji, H. Yin, W. E. Huang, J. Xu and 
B. Ma, Anal. Chem., 2015, 87, 2282-2289. 
61. M. Kaern, T. C. Elston, W. J. Blake and J. J. Collins, Nat Rev Genet, 2005, 6, 451-
464. 
62. M. B. Elowitz, A. J. Levine, E. D. Siggia and P. S. Swain, Science, 2002, 297, 1183-
1186. 
63. J. M. Raser and E. K. O'Shea, Science, 2004, 304, 1811-1814. 
64. A. P. Feinberg and R. A. Irizarry, Proc. Natl. Acad. Sci. U.S.A., 2010, 107, 1757-1764. 
65. J.-W. Veening, W. K. Smits and O. P. Kuipers, Annu. Rev. Microbiol., 2008, 62, 193-
210. 
66. P. Heraud and M. J. Tobin, Stem Cell Research, 2009, 3, 12-14. 
67. J. Heber, R. Sevenson and O. Boldman, Science, 1952, 116, ll. 
68. K. Norris, J. Hyg. (Lond.), 1959, 57, 326-345. 
69. F. L. Martin, J. G. Kelly, V. Llabjani, P. L. Martin-Hirsch, Patel, II, J. Trevisan, N. J. 
Fullwood and M. J. Walsh, Nat. Protoc., 2010, 5, 1748-1760. 
70. J. G. Kelly, J. Trevisan, A. D. Scott, P. L. Carmichael, H. M. Pollock, P. L. Martin-
Hirsch and F. L. Martin, J. Proteome Res., 2011, 10, 1437-1448. 
71. D. Naumann, D. Helm and H. Labischinski, Nature, 1991, 351, 81-82. 
72. M. J. Baker, J. Trevisan, P. Bassan, R. Bhargava, H. J. Butler, K. M. Dorling, P. R. 
Fielden, S. W. Fogarty, N. J. Fullwood, K. A. Heys, C. Hughes, P. Lasch, P. L. Martin-
Hirsch, B. Obinaju, G. D. Sockalingum, J. Sule-Suso, R. J. Strong, M. J. Walsh, B. R. 
Wood, P. Gardner and F. L. Martin, Nat. Protoc., 2014, 9, 1771-1791. 
73. J. Schmitt and H.-C. Flemming, Int. Biodeterior. Biodegradation, 1998, 41, 1-11. 
74. A. Bosch, D. Serra, C. Prieto, J. Schmitt, D. Naumann and O. Yantorno, Appl. 
Microbiol. Biotechnol., 2006, 71, 736-747. 
75. J. J. Ojeda, M. E. Romero-González, R. T. Bachmann, R. G. Edyvean and S. A. 
Banwart, Langmuir, 2008, 24, 4032-4040. 
76. B. R. Wood, M. A. Quinn, B. Tait, M. Ashdown, T. Hislop, M. Romeo and D. 
McNaughton, Biospectroscopy, 1998, 4, 75-91. 
77. W. B. Dunn and D. I. Ellis, TrAC Trends in Analytical Chemistry, 2005, 24, 285-294. 
78. L. Mariey, J. Signolle, C. Amiel and J. Travert, Vib Spectrosc., 2001, 26, 151-159. 
79. E. Lipiec, G. Birarda, J. Kowalska, J. Lekki, L. Vaccari, A. Wiecheć, B. Wood and W. 
Kwiatek, Radiat. Phys. Chem., 2013, 93, 135-141. 
80. H. J. Butler, L. Ashton, B. Bird, G. Cinque, K. Curtis, J. Dorney, K. Esmonde-White, 
N. J. Fullwood, B. Gardner, P. L. Martin-Hirsch, M. J. Walsh, M. R. McAinsh, N. 
Stone and F. L. Martin, Nat. Protoc., 2016, 11, 664-687. 
81. A. A. Ahmadzai, J. Trevisan, N. J. Fullwood, P. L. Carmichael, A. D. Scott and F. L. 
Martin, Mutagenesis, 2012, 27, 257-266. 
82. S. Creton, M. J. Aardema, P. L. Carmichael, J. S. Harvey, F. L. Martin, R. F. Newbold, 
M. R. O’Donovan, K. Pant, A. Poth and A. Sakai, Mutagenesis, 2012, 27, 93-101. 
83. K. Gajjar, J. Trevisan, G. Owens, P. J. Keating, N. J. Wood, H. F. Stringfellow, P. L. 
Martin-Hirsch and F. L. Martin, Analyst, 2013, 138, 3917-3926. 
84. J. Trevisan, P. P. Angelov, I. I. Patel, G. M. Najand, K. T. Cheung, V. Llabjani, H. M. 
Pollock, S. W. Bruce, K. Pant and P. L. Carmichael, Analyst, 2010, 135, 3266-3272. 
85. M. J. Walsh, S. W. Bruce, K. Pant, P. L. Carmichael, A. D. Scott and F. L. Martin, 
Toxicology, 2009, 258, 33-38. 
86. K. Kneipp, H. Kneipp, I. Itzkan, R. R. Dasari and M. S. Feld, Chem. Rev., 1999, 99, 
2957-2976. 
87. Z. Movasaghi, S. Rehman and I. U. Rehman, Appl. Surf. Sci., 2007, 42, 493-541. 
88. R. M. Jarvis and R. Goodacre, Anal. Chem., 2004, 76, 40-47. 
Page 20 of 22Integrative Biology
In
te
gr
at
iv
e
B
io
lo
gy
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
27
 A
pr
il 
20
17
. D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f C
en
tra
l L
an
ca
sh
ire
 o
n 
27
/0
4/
20
17
 1
4:
52
:2
0.
 
View Article Online
DOI: 10.1039/C7IB00009J
20 
 
89. K. Maquelin, C. Kirschner, L.-P. Choo-Smith, N. van den Braak, H. P. Endtz, D. 
Naumann and G. Puppels, J. Microbiol. Methods, 2002, 51, 255-271. 
90. S. Pahlow, S. Meisel, D. Cialla-May, K. Weber, P. Rösch and J. Popp, Adv. Drug 
Deliv. Rev., 2015, 89, 105-120. 
91. R. Goodacre, E. M. Timmins, P. J. Rooney, J. J. Rowland and D. B. Kell, FEMS 
Microbiol. Lett., 1996, 140, 233-239. 
92. D. I. Ellis, D. Broadhurst, D. B. Kell, J. J. Rowland and R. Goodacre, Appl. Environ. 
Microbiol., 2002, 68, 2822-2828. 
93. W. E. Huang, R. I. Griffiths, I. P. Thompson, M. J. Bailey and A. S. Whiteley, Anal. 
Chem., 2004, 76, 4452-4458. 
94. H. Li, F. L. Martin and D. Zhang, Anal. Chem., 2017, 89, 3909-3918. 
95. T. Schwartz, C. Jungfer, S. Heißler, F. Friedrich, W. Faubel and U. Obst, 
Chemosphere, 2009, 77, 249-257. 
96. E. Karunakaran, J. Mukherjee, B. Ramalingam and C. A. Biggs, Appl Microbiol 
Biotechnol, 2011, 90, 1869-1881. 
97. R. Alvarez, A. J. Burdette, X. Wu, C. Kotanen, Y. Zhao and R. A. Tripp, Rapid 
Identification of Bacterial Pathogens of Military Interest Using Surface-Enhanced 
Raman Spectroscopy, DTIC Document, 2014. 
98. P. N. Sampaio, B. Cunha, F. Rosa, K. Sales, M. Lopes and C. R. Calado, 2015. 
99. H. Zhou, D. Yang, N. P. Ivleva, N. E. Mircescu, S. Schubert, R. Niessner, A. Wieser 
and C. Haisch, Anal. Chem., 2015, 87, 6553-6561. 
100. A. A. Bunaciu, H. Y. Aboul-Enein and Ş. Fleschin, Appl. Surf. Sci., 2015, 50, 176-
191. 
101. U. Neugebauer, S. Trenkmann, T. Bocklitz, D. Schmerler, M. Kiehntopf and J. Popp, 
J. Biophotonics, 2014, 7, 232-240. 
102. W. Premasiri, D. Moir, M. Klempner, N. Krieger, G. Jones and L. Ziegler, J. Phys. 
Chem. B, 2005, 109, 312-320. 
103. P. Zarnowiec, L. Lechowicz, G. Czerwonka and W. Kaca, Curr. Med. Chem., 2015, 
22, 1710-1718. 
104. M. J. Riding, F. L. Martin, J. Trevisan, V. Llabjani, Patel, II, K. C. Jones and K. T. 
Semple, Environ. Pollut., 2012, 163, 226-234. 
105. K. A. Heys, M. J. Riding, R. J. Strong, R. F. Shore, M. G. Pereira, K. C. Jones, K. T. 
Semple and F. L. Martin, Analyst, 2014, 139, 896-905. 
106. J.-X. Cheng and X. S. Xie, Science, 2015, 350, aaa8870. 
107. L. Cui, P. Y. Chen, B. F. Zhang, D. Y. Zhang, J. Y. Li, F. L. Martin and K. S. Zhang, 
Water Res., 2015, 87, 282-291. 
108. Z. Movasaghi, S. Rehman and D. I. ur Rehman, Appl. Surf. Sci., 2008, 43, 134-179. 
109. S. Kumar, T. Verma, R. Mukherjee, F. Ariese, K. Somasundaram and S. Umapathy, 
Chem. Soc. Rev., 2016, 45, 1879-1900. 
110. J. Li, R. Strong, J. Trevisan, S. W. Fogarty, N. J. Fullwood, K. C. Jones and F. L. 
Martin, Environ. Sci. Technol., 2013, 47, 10005-10011. 
111. E. K. Costello, C. L. Lauber, M. Hamady, N. Fierer, J. I. Gordon and R. Knight, 
Science, 2009, 326, 1694-1697. 
112. C. L. Lauber, M. Hamady, R. Knight and N. Fierer, Appl. Environ. Microbiol., 2009, 
75, 5111-5120. 
113. P. Marschner, C.-H. Yang, R. Lieberei and D. Crowley, Soil Biol. Biochem., 2001, 33, 
1437-1445. 
114. M. Wietz, B. Wemheuer, H. Simon, H. A. Giebel, M. A. Seibt, R. Daniel, T. Brinkhoff 
and M. Simon, Environ. Microbiol., 2015, 17, 3822-3831. 
115. S. M. Ede, L. M. Hafner and P. M. Fredericks, Appl Spectrosc, 2004, 58, 317-322. 
Page 21 of 22 Integrative Biology
In
te
gr
at
iv
e
B
io
lo
gy
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
27
 A
pr
il 
20
17
. D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f C
en
tra
l L
an
ca
sh
ire
 o
n 
27
/0
4/
20
17
 1
4:
52
:2
0.
 
View Article Online
DOI: 10.1039/C7IB00009J
21 
 
116. M. R. Brown, D. G. Allison and P. GILBERT, J. Antimicrob. Chemother., 1988, 22, 
777-780. 
117. O. Fridman, A. Goldberg, I. Ronin, N. Shoresh and N. Q. Balaban, Nature, 2014, 513, 
418-421. 
118. C. G. Mayhall and E. Apollo, Antimicrob. Agents Chemother., 1980, 18, 784-788. 
119. C. G. Xie, D. Chen and Y. Q. Li, Optics Letters, 2005, 30, 1800-1802. 
120. K. Kogermann, M. Putrins and T. Tenson, Eur. J. Pharm. Sci., 2016, 95, 2-16. 
121. J. Trevisan, P. P. Angelov, P. L. Carmichael, A. D. Scott and F. L. Martin, Analyst, 
2012, 137, 3202-3215. 
122. W. B. Whitman, D. C. Coleman and W. J. Wiebe, Proc. Natl. Acad. Sci. U.S.A., 1998, 
95, 6578-6583. 
123. Y. Song, A.-K. Kaster, J. Vollmers, Y. Song, P. A. Davison, M. Frentrup, G. M. 
Preston, I. P. Thompson, J. C. Murrell and H. Yin, Microb. biotechnol., 2017, 10, 125-
137. 
124. T. Chen, C. Cao, J. Zhang, A. M. Streets, Y. Huang and T. Li, bioRxiv, 2017, 121616. 
125. K. R. Jonscher, A. Alfonso-Garcia, J. L. Suhalim, D. J. Orlicky, E. O. Potma, V. L. 
Ferguson, M. L. Bouxsein, T. A. Bateman, L. S. Stodieck and M. Levi, PLoS ONE, 
2016, 11, e0152877. 
 
Page 22 of 22Integrative Biology
In
te
gr
at
iv
e
B
io
lo
gy
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
27
 A
pr
il 
20
17
. D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f C
en
tra
l L
an
ca
sh
ire
 o
n 
27
/0
4/
20
17
 1
4:
52
:2
0.
 
View Article Online
DOI: 10.1039/C7IB00009J
